Among those with LV dysfunction, transfemoral TAVR was linked to better improvement in LVEF (difference = 4.04%; 95% CI, 2.39-5.69) and 6-minute walk distance (difference = 45.1 m; 95% CI, 18.4-71 ...

At 1 year, transapical TAVR carried higher risk of mortality compared with transvascular TAVR, even after adjusting for confounders (OR 1.398; 95% CI 1.217-1.606). Stroke and TIA remained equivalent ...

Transcatheter aortic valve replacement is safe, ... Both transfemoral and transapical approaches to TAVR appear to be safe and effective for treatment of aortic stenosis in select patients age 90 ...

While experience with transapical TAVR has grown in recent years, the lessons learned have failed to translate into improved quality of life (QoL) at 12 months compared with what was seen in the ...

The first trial will study alternatives to transfemoral approaches in 1,000 patients considered ineligible for aortic valve surgery. "Since transapical and transaortic [approaches] were not ...

Patients assigned to TAVR were treated by either the transfemoral or transapical approach on the basis of whether peripheral arteries could accommodate the large sheaths required (22 French for ...

Stroke rates at 30 days after transcatheter aortic valve replacement were similar across a number of comparisons between approach and valve type, according to findings published in the Journal of ...

Among patients only eligible for the transapical approach: TAVR provided no increase (and possible decrease) in QALYs TAVR increased procedural, index admission, and 12 month costs (by ~$10,000 ...

The transfemoral approach was used in 72.9% of the cohort, the transapical approach in 17.5%, and subclavian in 5.8% of the group. As judged by a lowered mean gradient, 97% of the procedures were ...